p53 MUTATIONS IN PROSTATE CANCER BONE METASTASES SUGGEST THAT SELECTED p53 MUTANTS IN THE PRIMARY SITE DEFINE FOCI WITH METASTATIC POTENTIAL
Authors:
- 1 January 1999
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 161 (1) , 304-308
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Expression of BCL-2 Oncoprotein and P53 Protein Accumulation in Bone Marrow Metastases of Androgen Independent Prostate CancerJournal of Urology, 1997
- Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate CancerNew England Journal of Medicine, 1995
- Frequency and characterization of p53 mutations in clinically localized prostate cancerUrology, 1995
- Cancer statistics, 1995CA: A Cancer Journal for Clinicians, 1995
- Management of Cancer of the ProstateNew England Journal of Medicine, 1994
- Immunohistochemical Determination of P53 Protein Nuclear Accumulation in Prostatic AdenocarcinomaJournal of Urology, 1994
- Frequency and characterization of p53 mutations in primary and metastatic human prostate cancerInternational Journal of Cancer, 1994
- P53 Oncogene Mutations in Human Prostate Cancer SpecimensJournal of Urology, 1994
- Small Subgroup of Aggressive, Highly Proliferative Prostatic Carcinomas Defined by p53 AccumulationJNCI: Journal of the National Cancer Institute, 1992
- Carcinoma of the ProstateNew England Journal of Medicine, 1991